U.S. Physical Therapy (USPH) to Release Quarterly Earnings on Wednesday

U.S. Physical Therapy (NYSE:USPH) is anticipated to issue its quarterly earnings data before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of $0.69 per share and revenue of $173.10 million for the quarter. Parties interested in registering for the company’s conference call can do so using this link.

U.S. Physical Therapy Stock Up 1.4 %

Shares of NYSE:USPH opened at $88.26 on Wednesday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. U.S. Physical Therapy has a 1 year low of $76.18 and a 1 year high of $113.63. The stock has a market capitalization of $1.33 billion, a P/E ratio of 93.89, a PEG ratio of 3.61 and a beta of 1.48. The stock has a 50-day simple moving average of $89.53 and a 200-day simple moving average of $87.83.

Insiders Place Their Bets

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the transaction, the chief financial officer now directly owns 20,469 shares of the company’s stock, valued at $1,970,141.25. This represents a 2.46 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 1.70% of the stock is owned by company insiders.

Analyst Ratings Changes

USPH has been the subject of a number of research reports. JPMorgan Chase & Co. boosted their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. JMP Securities began coverage on U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price target for the company. Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price target for the stock from $100.00 to $115.00 in a report on Monday, December 16th. Finally, Barrington Research restated an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a report on Thursday, November 21st. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, U.S. Physical Therapy currently has an average rating of “Buy” and an average price target of $114.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.